Hallador Energy Co (NASDAQ: HNRG) stock closed at $5.34 on 8/7/24 after a major decline of -21.9%. Moreover, trading volume in this decline was exceptionally high at 489% of normal. The stock has declined -27.6% […]
On 8/7/24, Gulf Island Fabrication Inc (NASDAQ: GIFI) stock suffered a major decline of -10.6%, closing at $5.40. Moreover, trading volume in this decline was exceptionally high at 479% of normal. The stock has declined […]
For its second fiscal quarter (ending June 30), EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported E.P.S. of $-0.58 compared to $-0.61 a year ago. This result fell short of the consensus estimate of $-0.53 by […]
Editas Medicine Inc (NASDAQ: EDIT) has reported E.P.S. of $-0.82 for its second fiscal quarter (ending June 30) versus $-0.56 for the same period a year ago. This performance was $-0.11 short of the consensus […]
For its second fiscal quarter (ending June 30), Ceva Inc (NASDAQ: CEVA) has reported E.P.S. of $-0.01 compared to $-0.20 a year ago. This performance was $-0.04 short of the consensus estimate of $0.03. E.P.S. […]
Astec Industries Inc. (NASDAQ: ASTE) has reported E.P.S. of $-0.61 for its second fiscal quarter (ending June 30) versus $0.58 for the same period a year ago — a decline of -205%. Relative to the […]
Amdocs Ltd (NASDAQ: DOX) has reported E.P.S. of $1.22 for its third fiscal quarter (ending June 30) versus $1.33 for the same period a year ago — a decline of -8%. Relative to the consensus […]
Alpha and Omega Semiconductor Li (NASDAQ: AOSL) has reported a loss for its fourth fiscal quarter (ending June 30) of $-0.09 versus a loss $-0.04 for the same period a year ago. This result fell […]
Voyager Therapeutics Inc (NASDAQ: VYGR) stock closed at $7.04 on 8/7/24 after a major decline of -14.0%. Moreover, this decline was accompanied by above average trading volume at 138% of normal. The stock has declined […]
Sunrun Inc (NASDAQ: RUN) stock enjoyed a major increase of 11.0% on 8/7/24. The shares closed at $18.31. Moreover, unusually high trading volume at 190% of normal accompanied the advance. The stock has performed in […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research